Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021:19:1976-1985.
doi: 10.1016/j.csbj.2021.04.002. Epub 2021 Apr 5.

AutoVEM: An automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution

Affiliations

AutoVEM: An automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution

Binbin Xi et al. Comput Struct Biotechnol J. 2021.

Abstract

With the global epidemic of SARS-CoV-2, it is important to effectively monitor the variation, haplotype subgroup epidemic trends and key mutations of SARS-CoV-2 over time. This is of great significance to the development of new vaccines, the update of therapeutic drugs, and the improvement of detection methods. The AutoVEM tool developed in the present study could complete all mutations detections, haplotypes classification, haplotype subgroup epidemic trends and candidate key mutations analysis for 131,576 SARS-CoV-2 genome sequences in 18 h on a 1 core CPU and 2 GB RAM computer. Through haplotype subgroup epidemic trends analysis of 131,576 genome sequences, the great significance of the previous 4 specific sites (C241T, C3037T, C14408T and A23403G) was further revealed, and 6 new mutation sites of highly linked (T445C, C6286T, C22227T, G25563T, C26801G and G29645T) were discovered for the first time that might be related to the infectivity, pathogenicity or host adaptability of SARS-CoV-2. In brief, we proposed an integrative method and developed an efficient automated tool to monitor haplotype subgroup epidemic trends and screen for the candidate key mutations in the evolution of SARS-CoV-2 over time for the first time, and all data could be updated quickly to track the prevalence of previous key mutations and new candidate key mutations because of high efficiency of the tool. In addition, the idea of combinatorial analysis in the present study can also provide a reference for the mutation monitoring of other viruses.

Keywords: Automated tool; Epidemic trends; Key mutations; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Workflow chart of AutoVEM tool.
Fig. 2
Fig. 2
Linkage analysis of the previous 9 specific sites.
Fig. 3
Fig. 3
Haplotype subgroup prevalence trends of the previous 9 specific sites. The numbers of haplotype subgroups of the previous 9 specific sites for 131,576 genomes with clear collection data detected in each country or region in chronological order. Countries or regions with a total number of genomes ≤ 100 were not shown in the figures.
Fig. 4
Fig. 4
Linkage analysis and haplotypes of the 6 new sites.
Fig. 5
Fig. 5
Linkage analysis of the 10 sites.
Fig. 6
Fig. 6
Haplotype subgroup prevalence trends of the 10 sites. The numbers of haplotype subgroups of the 10 sites for 131,576 genomes with clear collection data detected in each country or region in chronological order. Countries or regions with a total number of genomes ≤ 100 were not shown in the figures.

References

    1. COVID-19. Weekly Epidemiological Update. 2020.
    1. Hu B, Guo H, Zhou P, Shi Z. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2020. - PMC - PubMed
    1. Forster P., Forster L., Renfrew C., Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. PNAS. 2020;117(17):9241–9243. - PMC - PubMed
    1. Tang X., Wu C., Li X., Song Y., Yao X., Wu X. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020;7(6):1012–1023. - PMC - PubMed
    1. van Dorp L, Acman M, Richard D, Shaw LP, Ford CE, Ormond L, Owen CJ, Pang J, Tan CCS, Boshier FAT et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol 2020;83(104351). - PMC - PubMed

LinkOut - more resources